Unlike CJC-1295, it lacks the modifications that provide DPP-IV resistance
Another study on intranasal administration of BPC-157 in rats with rhinitis elicited anti-inflammatory effects in the nasal lining [17, 18]
An early clinical trial in 13 patients with type 2 diabetes found that a single intravenous infusion of 1,000 mg of lipoic acid improved insulin-stimulated glucose disposal (i.e., insulin sensitivity) by 50% compared to a placebo infusion (57)
The benefits of semaglutide were also observed to be largely independent of how much weight people lost in the first four and a half months of taking semaglutide, the study revealed
(2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension Eye Journal
Companies known to have submitted applications include established generic manufacturers such as Sandoz, Aspen Pharmacare, and Canadian company Vimy Pharma